AAD VMX 2021 Highlights

(optional)
Privacy Policy.


Available on the Medfyle App

Welcome to AAD VMX 2021 Highlights

The AAD VMX, from the American Academy of Dermatology, is the leading meeting for dermatology research, education, and clinical care worldwide. AAD VMX 2021, held April 23–25 fully online, brought together more than 7,000 attendees and streamed over 75 sessions covering the full breadth of dermatology. We are pleased to present these AAD VMX Highlights selections.

AAD Faculty interviews

 
Recent developments in topical and systemic treatments for acne
 
36
How common is acne, and what burden does it place on patients?
92
Traditionally, what have been the treatment options for acne?
135
What advances have been seen in topical treatments?
391
What are the main advantages and disadvantages of systemic treatments?
 
What’s new in dermatologic surgery and cosmetic dermatology
 
38
How has the COVID-19 pandemic affected dermatologic surgery and cosmetic dermatology?
313
What do you think is the single most important advance in dermatologic surgery made in recent years?
405
And what about cosmetic dermatology?
 
Controversies in rosacea
 
33
The National Rosacea Society released updated criteria for diagnosis of rosacea. You have been a critic of the prior diagnostic criteria from this group, do you feel this publication has a positive impact?
135
I know you have concerns. How do they translate into negative consequences in patient care?
385
The same group also published an article on standard management of rosacea last year. Do you agree with their recommendations?
522
Can you tell us about a couple of new studies you find exciting regarding possible therapeutic innovations?
See More

Expert overviews

 
 
 
 

Summaries

See More

Poster podcasts

See More
Post test Go to the VMX Feedback